@2024 Afarand., IRAN
ISSN: 2252-0805 The Horizon of Medical Sciences 2014;20(1):1-7
ISSN: 2252-0805 The Horizon of Medical Sciences 2014;20(1):1-7
Comparison of Bee Venom’s - and Aspirin’s Effect on Fructation of Human Hemoglobin
ARTICLE INFO
Article Type
Original ResearchAuthors
Behroozi J. (1)Divsalar A. (*)
(*) Cell & Molecular Biology Department, Biological Sciences Faculty, Kharazmi University, Tehran, Iran
(1) Cell & Molecular Biology Department, Biological Sciences Faculty, Kharazmi University, Tehran, Iran
Correspondence
Address: Cell & Molecular Biology Department, Biological Sciences Faculty, Kharazmi University, Shahid Mofatteh Street, Tehran, IranPhone: +982161113381
Fax: +982166404680
divsalar@khu.ac.ir
Article History
Received: September 29, 2013Accepted: March 6, 2014
ePublished: February 1, 2014
BRIEF TEXT
Glycation is non-enzymatic reaction of adding sugars to proteins, which goes on to form color full and fluorescence species with cross-joints named as AGE [5]. Fructose has tendency to form AGEs 8 to 10 times more than glucose does [6]. Aspirin is non-steroidal anti-inflammatory drug [7]. Melittin and phospholipase-A2 are two main components of bee venom [11]. There are various agents, which inhibit glycation in a manner. Lysine amino acid competes with amine protein group in binding to the sugar [14]; and aspirin connects with protein and inhibits sugar to reach amine factor [15].Some anti-oxidants, like bee venom, decrease glycation through glyco-oxidation.
Non-declared
The aim of the study was to assess anti fructation effect of bee venom, in comparison with aspirin.
The method is empirical.
Research society was the population of healthy and non-smoking persons.
According to Austen Riggs protocol [16], hemoglobin of healthy and non-smoking persons was extracted, and then, using Bradford method [17] and ultraviolet spectrometry, its concentration was determined. Bovine serum albumin (BSA) protein was used as standard protein. 10 mg per ml hemoglobin was incubated at the presence and absence of 40 mMol fructose for 5 weeks at 37℃ on shaker with 40 rpm velocity. To evaluate bee venom and aspirin’s effect, hemoglobin was fructated at the presence of these two materials. To study releasing value of heme group and hemoglobin’s soret band changes, protein and visible-ultraviolet spectrometry method were used, respectively. Value of free amines in hemoglobin was measured during fructation and at the presence of aspirin and bee venom, using method of changes in the florescamin fluorescence emission. To compute free amine percent, the equation [(alone hemoglobin fluorescence emission/ hemoglobin fluorescence emission at desired conditions)*100] was used. Spectro-polarimeter and circular bicolor spectrometry method (CD) were used to consider fructed hemoglobin protein structure changes. Samples were considered on the interval between 190 and 260 nm wavelengths.
UV-3100 (Shimadzu; Japan) visible-ultraviolet spectrometer, Merk (Germany) fructose, bee venom (Islamic Azad University, Sciences and Research Branch; Iran), aspirin (Sigma; USA), spectro-polarimeter (AVIV; USA) were used. Method of changes in the florescamin fluorescence emission was performed with Sigma (USA). To compute each second structure of protein, CDNN software was used [19]. Data were analyzed, using InStat 3 software and One-way Variance Analysis statistical tests.
Visible-ultraviolet spectrometry: At the presence of hemoglobin, hemoglobin incubation resulted in decrease in soret band of fructed hemoglobin absorption than hemoglobin does. In a concentration-dependent procedure, bee venom increased absorption. There was no significant difference between increase in absorption at the presence of 40 micrograms per milliliter bee venom and decrease in fructation at the presence of aspirin (Diagram 1). Fluorescence spectrometry: There was no significant difference between value of free amines at the presence of 20 and 40 microgram per milliliter bee venom and value of free amines at the presence of aspirin (Diagram 2). Circular bicolor spectrometry: During fructation and in a concentration-dependent procedure, bee venom prevented change in the second structure of hemoglobin. Aspirin, also, inhibited these changes, and it decreased significantly fructation as well as its followed up structure changes (Diagram 3). Fructation resulted in decrease in alpha helix in hemoglobin and, subsequently, increase in beta plates. Bee venom and aspirin had a significant effect in inhibition of these changes. 40 micrograms per milliliter bee venom had an approximately similar function with aspirin concerning inhibition of hemoglobin fructation and structure changes induced by it (Table 1).
Based on the results of a study, hemoglobin glycation results in decrease in soret absorption peak and its displacement [22], which is fully consistent with the results of the present study.
Non-declared
Non-declared
Fructation results in induction of structure changes in hemoglobin. Like aspirin, bee venom can inhibit formed changes in hemoglobin caused by fructation.
Researchers feel grateful to Research Deputy of Kharazmi University.
Non-declared
Non-declared
Research Deputy of Kharazmi University funded the study.
TABLES and CHARTS
Show attach fileCITIATION LINKS
[1]Hosseini SH, Amoghli Tabrizi B, Mazlom Moghaddam SSR. Evaluation at Ginseng on Lipid Profiles, Liver and Renal Markers in Diabetic Rats. ZUMS J. 2011;19(75):11-7.
[2]Ahmed N. Advanced glycation endproducts: role in pathology of diabetic complications. Diabetes Res Clin Pract. 2005;67(1):3-21.
[3]Koga M, Murai J, Saito H, Yamada Y, Mori T, Suno S, et al. Measurement of glycated hemoglobin and glycated albumin in umbilical cord: evaluation of the glycemic control indicators in neonates. J Perinatol. 2011;31(6):430-3.
[4]Nawale RB, Mourya VK, Bhise SB. Non-enzymatic glycation of proteins: a cause for complications in diabetes. Indian J Biochem Biophys. 2006;43(6):337-44.
[5]Daroux M, Prevost G, Maillard-Lefebvre H, Gaxatte C, D'Agati VD, Schmidt AM, et al. Advanced glycation end-products: implications for diabetic and non-diabetic nephropathies. Diabetes Metab. 2010;36(1):1-10.
[6]Takeuchi M, Iwaki M, Takino J, Shirai H, Kawakami M, Bucala R, et al. Immunological detection of fructose-derived advanced glycation end-products. Lab Invest. 2010;90(7):1117-27.
[7]Birmann BM, Giovannucci EL, Rosner BA, Colditz GA. Regular aspirin use and risk of multiple myeloma: a prospective analysis in the health professionals follow-up study and nurses' health study. Cancer Prev Res. 2014;7(1):33-41.
[8]Fitzgerald R, Pirmohamed M. Aspirin resistance: effect of clinical, biochemical and genetic factors. Pharmacol Ther. 2011;130(2):213-25.
[9]Tehrani S, Antovic A, Mobarrez F, Mageed K, Lins PE, Adamson U, et al. High-dose aspirin is required to influence plasma fibrin network structure in patients with type 1 diabetes. Diabetes Care. 2012;35(2):404-8.
[10]Harding JJ, Ganea E. Protection against glycation and similar post-translational modifications of proteins. Biochim Biophys Acta. 2006;1764(9):1436-46.
[11]Jang MH, Shin MC, Lim S, Han SM, Park HJ, Shin L, et al. Bee venom induces apoptosis and inhibits expression of cyclooxygenase-2 mRNA in human lung cancer cell line NCI-H1299. J Pharmacal Sci. 2003;91(2):95-104.
[12]Son DJ , Lee YH, Song SH, Lee CK, Hong JT. Therapeutic application of anti- arthritis, pain-releasing and anti-cancer effects of bee venom and its constituent compounds. Pharmacol Ther. 2007;115(2):246-70.
[13]Bathaie SZ, Jafarnejad A, Hosseinkhani S, Nakhjavani M. The effect of hot-tub therapy on serum Hsp70 level and its benefit on diabetic rats: a preliminary report. Int J Hyperthermia. 2010;26(6):577-85.
[14]Jafarnejad A, Bathaie SZ, Nakhjavani M, Hassan MZ, Banasadegh S. The improvement effect of L-Lys as a chemical chaperone on STZ-induced diabetic rats, protein structure and function. Diabetes Metab Res Rev. 2008;24(1):64-73.
[15]Jafarnejad A, Bathaie SZ, Nakhjavani M, Hassan MZ. Investigation of the mechanisms involved in the high-dose and long-term acetyl salicylic acid therapy of type I diabetic rats. J Pharmacol Exp Ther. 2008;324(2):850-7.
[16]Riggs A. Preparation of blood hemoglobins of vertebrates. Methods Enzymol. 1981;76:5-29.
[17]Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72(1):248-54.
[18]Schmitt A, Schmitt J, Münch G, Gasic-Milencovic J. Characterization of advanced glycation end products for biochemical studies: side chain modifications and fluorescence characteristics. Anal Biochem. 2005;338(2):201-15.
[19]Bakhti M, Moosavi-Movahedi AA, Khazaei MR. Consequential alterations in haemoglobin structure upon glycation with fructose: prevention by acetylsalicylic acid. J Biochem. 2007;141(6):827-33.
[20]Méndez JD, Xie J, Aguilar-Hernández M, Méndez-Valenzuela V. Molecular susceptibility to glycation and its implication in diabetes mellitus and related diseases. Mol Cell Biochem. 2010;344(1-2):185-93.
[21]Selvaraj N, Bobby Z, Sridhar MG. Increased glycation of hemoglobin in chronic renal failure: potential role of oxidative stress. Arch Med Res. 2008;39(3):277-84.
[22]Cussimanio BL, Booth AA, Todd P, Hudson BG, Khalifah RG. Unusual susceptibility of heme proteins to damage by glucose during non-enzymatic glycation. Biophys Chem. 2003;105(2-3):743-55.
[23]Rahbar S. The discovery of glycated hemoglobin: a major event in the study of nonenzymatic chemistry in biological systems. Ann NY Acad Sci. 2005;1043(1):9-19.
[24]Sen S, Kar M, Roy A, Chakraborti AS. Effect of nonenzymatic glycation on functional and structural properties of hemoglobin. Biophys Chem. 2005;113(3):289-98.
[25]Krautwald M, Münch G. Advanced glycation end products as biomarkers and gerontotoxins - A basis to explore methylglyoxal-lowering agents for Alzheimer's disease? Exp Gerontol. 2010;45(10):744-51.
[26]Peng X, Ma J, Chen F, Wang M. Naturally occurring inhibitors against the formation of advanced glycation end-products. Food Funct. 2011;2(6):289-301.
[27]Ansari NA, Dash D. Amadori glycated proteins: role in production of autoantibodies in diabetes mellitus and effect of inhibitors on non-enzymatic glycation. Aging Dis. 2013;4(1):50-6.
[28]Capuano E, Fedele F, Mennella C, Visciano M, Napolitano A, Lanzuise S, et al. Studies on the effect of Amadoriase from Aspergillus fumigatus on peptide and protein glycation in vitro. J Agri Food Chem. 2007;55(10):4189-95.
[29]Jomova K, Valko M. Importance of iron chelation in free radical-induced oxidative stress and human disease. Curr Pharm Des. 2011;17(31):3460-73.
[30]Jariyapamornkoon N, Yibchok-anun S, Adisakwattana S. Inhibition of advanced glycation end products by red grape skin extract and its antioxidant activity. BMC Complement Altern Med. 2013;13(1):171.
[31]Chen J, Lariviere WR. The nociceptive and antinociceptive effects of bee venom injection and therapy: A double-edged sword. Prog Neurobiol. 2010;92(2):151-83.
[32]Li R, Zhang L, Fang Y, Han B, Lu X, Zhou T, et al. Proteome and phosphoproteome analysis of honeybee (Apis mellifera) venom collected from electrical stimulation and manual extraction of the venom gland. BMC Genomics. 2013;14(1):766-87.
[33]Hood JL, Jallouk AP, Campbell N, Ratner L, Wickline SA. Cytolytic nanoparticles attenuate HIV-1 infectivity. Antivir Ther. 2013;18(1):95-103.
[2]Ahmed N. Advanced glycation endproducts: role in pathology of diabetic complications. Diabetes Res Clin Pract. 2005;67(1):3-21.
[3]Koga M, Murai J, Saito H, Yamada Y, Mori T, Suno S, et al. Measurement of glycated hemoglobin and glycated albumin in umbilical cord: evaluation of the glycemic control indicators in neonates. J Perinatol. 2011;31(6):430-3.
[4]Nawale RB, Mourya VK, Bhise SB. Non-enzymatic glycation of proteins: a cause for complications in diabetes. Indian J Biochem Biophys. 2006;43(6):337-44.
[5]Daroux M, Prevost G, Maillard-Lefebvre H, Gaxatte C, D'Agati VD, Schmidt AM, et al. Advanced glycation end-products: implications for diabetic and non-diabetic nephropathies. Diabetes Metab. 2010;36(1):1-10.
[6]Takeuchi M, Iwaki M, Takino J, Shirai H, Kawakami M, Bucala R, et al. Immunological detection of fructose-derived advanced glycation end-products. Lab Invest. 2010;90(7):1117-27.
[7]Birmann BM, Giovannucci EL, Rosner BA, Colditz GA. Regular aspirin use and risk of multiple myeloma: a prospective analysis in the health professionals follow-up study and nurses' health study. Cancer Prev Res. 2014;7(1):33-41.
[8]Fitzgerald R, Pirmohamed M. Aspirin resistance: effect of clinical, biochemical and genetic factors. Pharmacol Ther. 2011;130(2):213-25.
[9]Tehrani S, Antovic A, Mobarrez F, Mageed K, Lins PE, Adamson U, et al. High-dose aspirin is required to influence plasma fibrin network structure in patients with type 1 diabetes. Diabetes Care. 2012;35(2):404-8.
[10]Harding JJ, Ganea E. Protection against glycation and similar post-translational modifications of proteins. Biochim Biophys Acta. 2006;1764(9):1436-46.
[11]Jang MH, Shin MC, Lim S, Han SM, Park HJ, Shin L, et al. Bee venom induces apoptosis and inhibits expression of cyclooxygenase-2 mRNA in human lung cancer cell line NCI-H1299. J Pharmacal Sci. 2003;91(2):95-104.
[12]Son DJ , Lee YH, Song SH, Lee CK, Hong JT. Therapeutic application of anti- arthritis, pain-releasing and anti-cancer effects of bee venom and its constituent compounds. Pharmacol Ther. 2007;115(2):246-70.
[13]Bathaie SZ, Jafarnejad A, Hosseinkhani S, Nakhjavani M. The effect of hot-tub therapy on serum Hsp70 level and its benefit on diabetic rats: a preliminary report. Int J Hyperthermia. 2010;26(6):577-85.
[14]Jafarnejad A, Bathaie SZ, Nakhjavani M, Hassan MZ, Banasadegh S. The improvement effect of L-Lys as a chemical chaperone on STZ-induced diabetic rats, protein structure and function. Diabetes Metab Res Rev. 2008;24(1):64-73.
[15]Jafarnejad A, Bathaie SZ, Nakhjavani M, Hassan MZ. Investigation of the mechanisms involved in the high-dose and long-term acetyl salicylic acid therapy of type I diabetic rats. J Pharmacol Exp Ther. 2008;324(2):850-7.
[16]Riggs A. Preparation of blood hemoglobins of vertebrates. Methods Enzymol. 1981;76:5-29.
[17]Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72(1):248-54.
[18]Schmitt A, Schmitt J, Münch G, Gasic-Milencovic J. Characterization of advanced glycation end products for biochemical studies: side chain modifications and fluorescence characteristics. Anal Biochem. 2005;338(2):201-15.
[19]Bakhti M, Moosavi-Movahedi AA, Khazaei MR. Consequential alterations in haemoglobin structure upon glycation with fructose: prevention by acetylsalicylic acid. J Biochem. 2007;141(6):827-33.
[20]Méndez JD, Xie J, Aguilar-Hernández M, Méndez-Valenzuela V. Molecular susceptibility to glycation and its implication in diabetes mellitus and related diseases. Mol Cell Biochem. 2010;344(1-2):185-93.
[21]Selvaraj N, Bobby Z, Sridhar MG. Increased glycation of hemoglobin in chronic renal failure: potential role of oxidative stress. Arch Med Res. 2008;39(3):277-84.
[22]Cussimanio BL, Booth AA, Todd P, Hudson BG, Khalifah RG. Unusual susceptibility of heme proteins to damage by glucose during non-enzymatic glycation. Biophys Chem. 2003;105(2-3):743-55.
[23]Rahbar S. The discovery of glycated hemoglobin: a major event in the study of nonenzymatic chemistry in biological systems. Ann NY Acad Sci. 2005;1043(1):9-19.
[24]Sen S, Kar M, Roy A, Chakraborti AS. Effect of nonenzymatic glycation on functional and structural properties of hemoglobin. Biophys Chem. 2005;113(3):289-98.
[25]Krautwald M, Münch G. Advanced glycation end products as biomarkers and gerontotoxins - A basis to explore methylglyoxal-lowering agents for Alzheimer's disease? Exp Gerontol. 2010;45(10):744-51.
[26]Peng X, Ma J, Chen F, Wang M. Naturally occurring inhibitors against the formation of advanced glycation end-products. Food Funct. 2011;2(6):289-301.
[27]Ansari NA, Dash D. Amadori glycated proteins: role in production of autoantibodies in diabetes mellitus and effect of inhibitors on non-enzymatic glycation. Aging Dis. 2013;4(1):50-6.
[28]Capuano E, Fedele F, Mennella C, Visciano M, Napolitano A, Lanzuise S, et al. Studies on the effect of Amadoriase from Aspergillus fumigatus on peptide and protein glycation in vitro. J Agri Food Chem. 2007;55(10):4189-95.
[29]Jomova K, Valko M. Importance of iron chelation in free radical-induced oxidative stress and human disease. Curr Pharm Des. 2011;17(31):3460-73.
[30]Jariyapamornkoon N, Yibchok-anun S, Adisakwattana S. Inhibition of advanced glycation end products by red grape skin extract and its antioxidant activity. BMC Complement Altern Med. 2013;13(1):171.
[31]Chen J, Lariviere WR. The nociceptive and antinociceptive effects of bee venom injection and therapy: A double-edged sword. Prog Neurobiol. 2010;92(2):151-83.
[32]Li R, Zhang L, Fang Y, Han B, Lu X, Zhou T, et al. Proteome and phosphoproteome analysis of honeybee (Apis mellifera) venom collected from electrical stimulation and manual extraction of the venom gland. BMC Genomics. 2013;14(1):766-87.
[33]Hood JL, Jallouk AP, Campbell N, Ratner L, Wickline SA. Cytolytic nanoparticles attenuate HIV-1 infectivity. Antivir Ther. 2013;18(1):95-103.